Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSCAR: IA vs IV Oxaliplatin for Liver-Limited Metastatic Colorectal Cancer
NCT02885753Phase 3Recruiting
- Sponsor
- Fédération Francophone de Cancérologie Digestive
- Start
- Dec 2016
- Primary completion
- Sep 2028
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 3 trial of oxaliplatin in colorectal cancer (CRC), sponsored by Fédération Francophone de Cancérologie Digestive. Started Dec 2016; status: recruiting.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02885753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02885753.